Press release
Bacterial Pneumonia Market Rises on Tech Diagnostics & Japan's Aging Population | Innoviva Inc., Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics LLC, Evopoint Biosciences
Bacterial Pneumonia Market
Bacterial Pneumonia Market Report by DataM Intelligence offers a detailed assessment of the global respiratory and infectious-disease landscape, highlighting market size, key players, and critical growth drivers. With evolving stewardship programs, rapid pathogen diagnostics, and new severity-stratified care pathways, the report delivers strategic insights for stakeholders from 2025 to 2033.
In 2025, professional societies released updated guidance (notably a July 2025 ATS update addressing severe CAP) and hospitals increased adoption of rapid diagnostic algorithms to better target antibiotics both trends impacting diagnostics, antimicrobial stewardship tools, and acute-care therapeutics demand in the U.S. market.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/bacterial-pneumonia-market?ophp
Bacterial Pneumonia Market Competitors Overview:
Innoviva Inc., Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics LLC, Evopoint Biosciences, Aridis Pharmaceuticals Inc., Cumberland Pharmaceuticals Inc., Eagle Pharmaceuticals, Inc., Clarametyx Biosciences and Basilea Pharmaceutica Ltd among others.
Important Industry Updates:
On July 27, 2023, Merck released encouraging topline findings from two Phase III studies assessing V116, the company's experimental 21-valent pneumococcal conjugate Drugs, in those who had never received a Drugs before and those who had. The first pneumococcal conjugate vaccination created especially for adults, if authorized, would be V116. Results from the STRIDE-3 trial showed that in adults who had never received a Drugs, serotype-specific opsonophagocytic activity (OPA) measured 30 days after vaccination revealed significant immune responses in comparison with PCV20 (pneumococcal 20-valent conjugate Drugs).
On June 1, 2023, the Phase III program, which included the ASSEMBLE (NCT03580044) and REVISIT (NCT03329092) studies evaluating the effectiveness, safety, and acceptability of the newly developed investigational antibiotic aztreonam-avibactam (ATM-AVI) combination in treating severe bacterial infections caused by Gram-negative bacteria, has produced encouraging results, according to Innoviva Inc. Data show that ATM-AVI is safe, efficacious, well-tolerated, and has an identical safety profile to that of aztreonam alone.
Methodology and Scope
The Bacterial Pneumonia Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/bacterial-pneumonia-market?ophp
Bacterial Pneumonia Market Segments Overview:
By Type {Community-Acquired Pneumonia (CAP), Hospital-Acquired Pneumonia (HAP) (Ventilator-associated pneumonia (VAP), Healthcare-associated pneumonia (HCAP))} By Route of Administration (Oral, Subcutaneous, Others) By Treatments {Vaccines (Pneumococcal Conjugate Vaccines, Pneumococcal Polysaccharide Vaccine), Drugs (Fluoroquinolones, Monobactams, Tetracyclines, Macrolides, Carbapenems, Antibiotics)} By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
Regional Overview for Bacterial Pneumonia Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=bacterial-pneumonia-market
The Report Covers:
âž¡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
âž¡ Strategic recommendations with a focused go-to-market approach.
âž¡ An unbiased evaluation of overall market performance.
âž¡ Region- and country-specific insights, with customized reports available upon request.
âž¡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Bacterial Pneumonia market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Bacterial Pneumonia market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bacterial Pneumonia Market Rises on Tech Diagnostics & Japan's Aging Population | Innoviva Inc., Pfizer Inc., Merck & Co., Inc., Melinta Therapeutics LLC, Evopoint Biosciences here
News-ID: 4142680 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
Smart Hearing Aids with Speech Recognition Technology Market | Trends, Growth & …
Market size and Growth
Global Smart Hearing Aids with Speech Recognition Technology Market reached US$ 7.87 billion in 2024 and is expected to reach US$ 30.83 billion by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.
DataM Intelligence has released its latest research, "Smart Hearing Aids with Speech Recognition Technology Market Size 2025," providing a detailed overview of the industry. The report offers a deep dive into key…
Cancer pain market driven by minimally invasive and robotic trocar innovations a …
The global cancer pain market was valued at US$ 7.45 Billion in 2023. The market size reached US$ 7.82 Billion in 2024 and is expected to reach US$ 12.45 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033.
Cancer Pain Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM…
HELLP Syndrome Market Growth Driven by Critical Advancements, Increasing Awarene …
Market Overview:
The HELLP Syndrome Market Size was valued at USD 1.72 billion in 2024. The market is projected to grow from USD 1.82 billion in 2025 to USD 2.85 billion by 2034, registering a CAGR of around 5.05% during 2025-2034.
HELLP Syndrome Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses…
Cryotherapy Facial Devices Market | Future Growth, Demand Surge & Innovations
Market Size and Growth
Global Cryotherapy Facial Devices Market reached US$ 338.70 million in 2024 and is expected to reach US$ 1326.93 million by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.
DataM Intelligence has released its latest research, "Cryotherapy Facial Devices Market Size 2025," providing a detailed overview of the industry. The report offers a deep dive into key market drivers, regional growth, and the competitive landscape,…
More Releases for Pneumonia
Pneumonia Testing Market: Trends, Opportunities, and Challenges
The global pneumonia testing market is experiencing steady growth, valued at $1.6 billion in 2020 and projected to reach $3.0 billion by 2030, at a CAGR of 6.5% (2021-2030). Pneumonia, a serious respiratory infection, remains a leading cause of morbidity and mortality worldwide. With advancements in diagnostic technologies and increased healthcare awareness, the market for pneumonia testing is expanding rapidly.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/3776
Key Market Drivers
• Rise…
Prominent Pneumonia Therapeutics Market Trend for 2025: Innovative Approaches To …
How Are the key drivers contributing to the expansion of the pneumonia therapeutics market?
The rising prevalence of pneumonia is expected to propel the growth of the pneumonia therapeutics market. Pneumonia, a lung infection, is becoming more widespread due to factors such as aging populations, air pollution, smoking, and the spread of respiratory infections like COVID-19 and influenza. Pneumonia therapeutics are essential in managing pneumonia, using targeted medications and therapies like…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Market Definitions of Bacterial Pneumonia Treatment
Global Bacterial Pneumonia Treatment Market: Overview
Bacterial pneumonia is an inflammation of the lungs due to bacterial infection. Pneumonia is a common lung infection where the lung’s air sacks become inflamed. Different types of bacteria can cause pneumonia, but Streptococcus pneumonia and Haemophilus influenza are primarily responsible for most of the bacterial pneumonia. Common indications of bacterial pneumonia include cough, chest pain, shortness of breath, fever, and chills.
Read Report Overview -…
Industry Dynamics of Ventilator-associated Pneumonia
Ventilator associated pneumonia (VAP) is an intensive care unit (ICU) for acquired infection. This pulmonary infection generally occurs 48 hours after a patient is incubated and has received mechanical ventilation. Incidence of VAP ranges from 6% to 55% and can reach up to 76% in some situations. VAP is a major cause of illness and death. Patients suffering with VAP have increased spans of ICU hospitalization. Moreover, death rate has…
Global Interstitial Pneumonia Market Growth 2020-2025
Global Interstitial Pneumonia Market Overview:
The global Interstitial Pneumonia market is expected to grow at a significant pace, reports GLOBAL INFO RESEARCH. Its latest research report, titled [Global and United States Interstitial Pneumonia Market 2020 by Company, Type and Application, Forecast to 2025], offers a unique point of view about the global market. Analysts believe that the changing consumption patterns are expected to have a great influence on the overall market. For a…
